|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM277882087 |
003 |
DE-627 |
005 |
20231225015321.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2017 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.3928/23258160-20171030-04
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0926.xml
|
035 |
|
|
|a (DE-627)NLM277882087
|
035 |
|
|
|a (NLM)29121358
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Stephens, John D
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Optical Coherence Tomography Findings in Endogenous Fungal Chorioretinitis, Retinitis, and Endophthalmitis
|
264 |
|
1 |
|c 2017
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 27.11.2017
|
500 |
|
|
|a Date Revised 09.12.2020
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright 2017, SLACK Incorporated.
|
520 |
|
|
|a BACKGROUND AND OBJECTIVE: To describe spectral-domain optical coherence tomography (SD-OCT) findings in eyes with endogenous fungal chorioretinitis and endophthalmitis
|
520 |
|
|
|a PATIENTS AND METHODS: Retrospective, observational case series of subjects at Wills Eye Hospital and William Beaumont Hospital were identified by screening OCT billing data and cross-referencing with patient charts. Clinical and imaging data were collected for each patient and reviewed
|
520 |
|
|
|a RESULTS: Twelve eyes of seven consecutive patients were identified, demonstrating two patterns of posterior ocular involvement: chorioretinal infiltration and superficial retinal/retinal vascular infiltration without choroidal involvement. Six of 12 eyes had follow-up imaging performed after antifungal treatment, which demonstrated decreased size of choroidal and/or retinal infiltrates
|
520 |
|
|
|a CONCLUSIONS: All patients with follow-up imaging had anatomic improvement by OCT of the lesions with treatment. In the future, OCT imaging may provide a method to assess therapeutic response and prognosis for visual recovery in patients with endogenous fungal ocular disease. [Ophthalmic Surg Lasers Imaging Retina. 2017;48:894-901.]
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Multicenter Study
|
650 |
|
4 |
|a Observational Study
|
650 |
|
7 |
|a Antifungal Agents
|2 NLM
|
700 |
1 |
|
|a Adam, Murtaza K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Todorich, Bohzo
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Faia, Lisa J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Garg, Sunir
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dunn, James P
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mehta, Sonia
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Ophthalmic surgery, lasers & imaging retina
|d 2013
|g 48(2017), 11 vom: 01. Nov., Seite 894-901
|w (DE-627)NLM224956647
|x 2325-8179
|7 nnns
|
773 |
1 |
8 |
|g volume:48
|g year:2017
|g number:11
|g day:01
|g month:11
|g pages:894-901
|
856 |
4 |
0 |
|u http://dx.doi.org/10.3928/23258160-20171030-04
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_63
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_90
|
912 |
|
|
|a GBV_ILN_91
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_135
|
912 |
|
|
|a GBV_ILN_136
|
912 |
|
|
|a GBV_ILN_151
|
912 |
|
|
|a GBV_ILN_181
|
912 |
|
|
|a GBV_ILN_203
|
912 |
|
|
|a GBV_ILN_217
|
912 |
|
|
|a GBV_ILN_235
|
912 |
|
|
|a GBV_ILN_289
|
912 |
|
|
|a GBV_ILN_294
|
912 |
|
|
|a GBV_ILN_297
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_352
|
912 |
|
|
|a GBV_ILN_674
|
912 |
|
|
|a GBV_ILN_676
|
912 |
|
|
|a GBV_ILN_688
|
912 |
|
|
|a GBV_ILN_698
|
912 |
|
|
|a GBV_ILN_721
|
912 |
|
|
|a GBV_ILN_737
|
912 |
|
|
|a GBV_ILN_791
|
912 |
|
|
|a GBV_ILN_812
|
951 |
|
|
|a AR
|
952 |
|
|
|d 48
|j 2017
|e 11
|b 01
|c 11
|h 894-901
|